172 related articles for article (PubMed ID: 10825611)
1. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.
Hart MK; Caswell-Stephan K; Bakken R; Tammariello R; Pratt W; Davis N; Johnston RE; Smith J; Steele K
Vaccine; 2000 Jul; 18(26):3067-75. PubMed ID: 10825611
[TBL] [Abstract][Full Text] [Related]
2. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice.
Hart MK; Pratt W; Panelo F; Tammariello R; Dertzbaugh M
Vaccine; 1997 Mar; 15(4):363-9. PubMed ID: 9141206
[TBL] [Abstract][Full Text] [Related]
3. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
[TBL] [Abstract][Full Text] [Related]
4. Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice.
Hart MK; Lind C; Bakken R; Robertson M; Tammariello R; Ludwig GV
Vaccine; 2001 Nov; 20(3-4):616-22. PubMed ID: 11672929
[TBL] [Abstract][Full Text] [Related]
5. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
[TBL] [Abstract][Full Text] [Related]
6. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
[TBL] [Abstract][Full Text] [Related]
7. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine.
Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
Vaccine; 1998 Aug; 16(13):1314-23. PubMed ID: 9682396
[TBL] [Abstract][Full Text] [Related]
8. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice.
Ludwig GV; Turell MJ; Vogel P; Kondig JP; Kell WK; Smith JF; Pratt WD
Am J Trop Med Hyg; 2001; 64(1-2):49-55. PubMed ID: 11425162
[TBL] [Abstract][Full Text] [Related]
9. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus.
Gupta P; Sharma A; Spurgers KB; Bakken RR; Eccleston LT; Cohen JW; Honnold SP; Glass PJ; Maheshwari RK
Vaccine; 2016 May; 34(25):2762-5. PubMed ID: 27129427
[TBL] [Abstract][Full Text] [Related]
10. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters.
Jahrling PB; Stephenson EH
J Clin Microbiol; 1984 Mar; 19(3):429-31. PubMed ID: 6715512
[TBL] [Abstract][Full Text] [Related]
11. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus.
Elvin SJ; Bennett AM; Phillpotts RJ
J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032
[TBL] [Abstract][Full Text] [Related]
12. Immunity to airborne challenge with Venezuelan equine encephalitis virus develops rapidly after immunization with the attenuated vaccine strain TC-83.
Phillpotts RJ
Vaccine; 1999 May; 17(19):2429-35. PubMed ID: 10392625
[TBL] [Abstract][Full Text] [Related]
13. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection.
Turell MJ; Parker MD
Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440
[TBL] [Abstract][Full Text] [Related]
14. Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.
Samsa MM; Dupuy LC; Beard CW; Six CM; Schmaljohn CS; Mason PW; Geall AJ; Ulmer JB; Yu D
Mol Ther; 2019 Apr; 27(4):850-865. PubMed ID: 30770173
[TBL] [Abstract][Full Text] [Related]
15. An immunological profile of Balb/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine.
Bennett AM; Elvin SJ; Wright AJ; Jones SM; Phillpotts RJ
Vaccine; 2000 Sep; 19(2-3):337-47. PubMed ID: 10930689
[TBL] [Abstract][Full Text] [Related]
16. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV
Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163
[TBL] [Abstract][Full Text] [Related]
17. Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice.
Steele KE; Davis KJ; Stephan K; Kell W; Vogel P; Hart MK
Vet Pathol; 1998 Sep; 35(5):386-97. PubMed ID: 9754544
[TBL] [Abstract][Full Text] [Related]
18. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus.
Bennett AM; Lescott T; Phillpotts RJ
Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402
[TBL] [Abstract][Full Text] [Related]
19. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.
Pratt WD; Gibbs P; Pitt ML; Schmaljohn AL
Vaccine; 1998; 16(9-10):1056-64. PubMed ID: 9682359
[TBL] [Abstract][Full Text] [Related]
20. Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models.
Pratt WD; Davis NL; Johnston RE; Smith JF
Vaccine; 2003 Sep; 21(25-26):3854-62. PubMed ID: 12922119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
